An interventional, randomized, double-blind, placebo-controlled, parallel-assignment, safety/efficacy study for treatment of chronic middle ear infection in adult patients with the antimicrobial peptide OP-145

Trial Profile

An interventional, randomized, double-blind, placebo-controlled, parallel-assignment, safety/efficacy study for treatment of chronic middle ear infection in adult patients with the antimicrobial peptide OP-145

Completed
Phase of Trial: Phase I/II

Latest Information Update: 21 Oct 2015

At a glance

  • Drugs OP 145 (Primary)
  • Indications Otitis media
  • Focus Therapeutic Use
  • Sponsors OctoPlus
  • Most Recent Events

    • 21 Oct 2015 New source identified and integrated (ISRCTN - 12149720|).
    • 12 Sep 2009 Results reported at ICAAC 2009.
    • 28 Jul 2008 Complete and final study results are expected to be available by the end of 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top